Discover
BBLG
Bone Biologics Corporation
0.93
1 x 0.94
1 x 1.09
bid
ask
+
0.00
0.25%
5 @ 04:00 PM
0.94 +0.00 (0.33%)
| Ytd | -35.69% | |
| 1y | -63.29% |
0.89
day range
0.99
0.85
52 week range
2.85
| Open | 0.99 | Prev Close | 0.93 | Low | 0.89 | High | 0.99 | Mkt Cap | 1.69M |
| Vol | 35.10K | Avg Vol | 65.59K | EPS | -2.27 | P/E | -0.41 | Forward P/E | -0.41 |
| Beta | 0.74 | Short Ratio | 0.18 | Inst. Own | 4.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.25 | 200-d Avg | 1.47 | 1yr Est | 16.75 |
| Income Statement | |||
| Operating Expenses | 805.05K | ||
| Research and Development Expense | 141.60K | ||
| Selling, General and Administrative Expense | 663.46K | ||
| Operating Income | -805.05K | ||
| Net Income | -765.99K | ||
| Net Income Common Stock | -765.99K | ||
| Net Income Common Stock (USD) | -765.99K | ||
| Consolidated Income | -765.99K | ||
| Earnings per Basic Share | -0.43 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -765.99K | ||
| Earning Before Interest & Taxes (USD) | -765.99K | ||
| Weighted Average Shares | 1.80M | ||
| Weighted Average Shares Diluted | 1.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.53M | ||
| Cash and Equivalents (USD) | 4.53M | ||
| Current Assets | 4.98M | ||
| Total Assets | 4.98M | ||
| Current Liabilities | 309.39K | ||
| Total Liabilities | 309.39K | ||
| Accumulated Retained Earnings (Deficit) | -88.90M | ||
| Shareholders Equity | 4.67M | ||
| Shareholders Equity (USD) | 4.67M | ||
| Trade and Non-Trade Payables | 308.95K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -804.28K | ||
| Net Cash Flow from Operations | -804.28K | ||
| Share Based Compensation | 23.51K | ||